|
Market Closed -
OTC Markets
20:32:11 11/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 18.50 USD | +14.20% |
|
-.--% | - |
| 10-27 | Exosens (-7%) hit by slumping profitability, analysts remain confident |  |
| 10-27 | Exosens Q3 revenue rises 23.5% on stronger demand, capacity ramp-up | RE |
Chart: Technical Analysis
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| EXENS | Real-time | |
CBOE
| Real-time | ||
|
Börse Stuttgart
| H8Y | Delayed | |
|
Tradegate
| H8Y | Real-time | |
|
Boerse Muenchen
| H8Y | Real-time | |
|
Deutsche Boerse AG
| H8Y | Delayed | |
|
CBOE
| 0EXO | Real-time | |
|
London S.E.
| 0EXO | Delayed | |
OTC Markets
| EXSNY | Delayed | |
|
Deutsche Boerse AG
| H8Y0 | Delayed |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EXENS Stock
- EXSNY Stock
- Charts Exosens
Select your edition
All financial news and data tailored to specific country editions
